Orphazyme announces update on in-court restructuring proceedings

Copenhagen, Denmark, April 29, 2022 Orphazyme A/S in restructuring (ORPHA.CO; ORPH) (Orphazyme or the Company), a late-stage biopharmaceutical company, announces an update to the in-court restructuring proceedings of the Company (please see company announcement no.